150 related articles for article (PubMed ID: 37424146)
21. [What should we know about cardiac amyloidosis? From clinical signs to treatment].
Földeák D; Nemes A; Kalapos A; Domsik P; Kormányos Á; Krenács L; Bagdi E; Borbényi Z
Orv Hetil; 2017 Nov; 158(46):1811-1818. PubMed ID: 29135289
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
[No Abstract] [Full Text] [Related]
23. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
[TBL] [Abstract][Full Text] [Related]
24. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
[TBL] [Abstract][Full Text] [Related]
25. [State-of-the-art review on the non-invasive diagnosis approaches of patients with transthyretin cardiac amyloidosis].
He S; Tian Z; Zhang SY
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):276-279. PubMed ID: 32370477
[TBL] [Abstract][Full Text] [Related]
26. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
[TBL] [Abstract][Full Text] [Related]
27. [Ten questions about transthyretin amyloidosis].
Giovannetti A; Accietto A; Massa P; Leone O; Guaraldi P; Saturi G; Caponetti AG; Sguazzotti M; Ponziani A; Gagliardi C; Galiè N; Cortelli P; Longhi S; Biagini E
G Ital Cardiol (Rome); 2022 Sep; 23(9):676-685. PubMed ID: 36039718
[TBL] [Abstract][Full Text] [Related]
28. Unravelling the role of sex in the pathophysiology, phenotypic expression and diagnosis of cardiac amyloidosis.
Rapezzi C; Emdin M; Aimo A
Eur J Heart Fail; 2022 Dec; 24(12):2364-2366. PubMed ID: 36059061
[TBL] [Abstract][Full Text] [Related]
29. Acute cardiac failure secondary to senile systemic amyloidosis.
Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
[TBL] [Abstract][Full Text] [Related]
30. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
[TBL] [Abstract][Full Text] [Related]
31. Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
Narotsky DL; Castano A; Weinsaft JW; Bokhari S; Maurer MS
Can J Cardiol; 2016 Sep; 32(9):1166.e1-1166.e10. PubMed ID: 27568874
[TBL] [Abstract][Full Text] [Related]
32. Disparities, Uncertainties, and Societal Cost: Precision Medicine and Transthyretin Amyloidosis.
Hauptman PJ; Wall JS; Maurer MS
Am J Med; 2020 Aug; 133(8):892-894. PubMed ID: 32268147
[No Abstract] [Full Text] [Related]
33. A Reliable Baton Passing From Orthopedic Surgeon to Cardiologist - Cardiac Screening in Patients With Carpal Tunnel Syndrome for Early Diagnosis of Transthyretin Amyloid Cardiomyopathy.
Ikura H; Kitakata H; Endo J
Circ J; 2023 Jul; 87(8):1056-1057. PubMed ID: 37438146
[No Abstract] [Full Text] [Related]
34. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
35. Misconceptions and Facts About Cardiac Amyloidosis.
Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
[TBL] [Abstract][Full Text] [Related]
36. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
Khedraki R
Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and clinical manifestations of cardiac amyloidosis.
Bajwa F; O'Connor R; Ananthasubramaniam K
Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
[TBL] [Abstract][Full Text] [Related]
38. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
Maurer MS; Bokhari S; Damy T; Dorbala S; Drachman BM; Fontana M; Grogan M; Kristen AV; Lousada I; Nativi-Nicolau J; Cristina Quarta C; Rapezzi C; Ruberg FL; Witteles R; Merlini G
Circ Heart Fail; 2019 Sep; 12(9):e006075. PubMed ID: 31480867
[TBL] [Abstract][Full Text] [Related]
39. Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
Varedi D; Kovacsovics T; Downs Kelly E; Abraham J; Cowley J; Barrell K; Revelo MP; Stehlik J; Drakos S; Marrouche N; Wilson B; Swanson EA; Fang J; Nativi-Nicolau J
Circ Heart Fail; 2018 Jul; 11(7):e004812. PubMed ID: 29921704
[No Abstract] [Full Text] [Related]
40. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]